CANCER TREATMENT USING MTDP INHIBITORS AND PLK1 INHIBITORS
Application
US20260076970A1
Kind: A1
Mar 19, 2026
Inventors
Maya Ridinger, Tod Smeal, Mark Erlander
Abstract
Provided include methods, compositions and kits for treating cancer in a subject. The method can comprise administrating an MTDP inhibitor (for example, paclitaxel) and a PLK1 inhibitor (for example, onvansertib) to the subject in a manner sufficient to inhibit or reduce progression of the cancer.
CPC Classifications
A61K 31/519
A61K 31/337
A61P 35/00
Filing Date
2023-09-08
Application No.
19109426